Current Opinion in Pulmonary Medicine

Papers
(The TQCC of Current Opinion in Pulmonary Medicine is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis46
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis35
The persistent problem of persistent air-leaks: approach to management33
Thoracic empyema: aetiology, diagnosis, treatment, and prevention33
Home monitoring in asthma: towards digital twins30
Bronchoscopic treatment of early-stage peripheral lung cancer30
The role of PET in the management of sarcoidosis28
Improving care in lung cancer surgery: a review of quality measures and evolving standards24
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?22
Digital outcome measures in pulmonary clinical trials22
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?22
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis22
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?20
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease19
Implementation of digital home monitoring and management of respiratory disease19
Considerations and clinical management of infections in sarcoidosis18
Group 2 pulmonary hypertension: from diagnosis to treatment18
Lung transplant referral considerations for individuals with cystic fibrosis17
The future of clinical trials in idiopathic pulmonary fibrosis17
Editorial introductions17
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions16
Asthma in pregnancy: a review of recent literature16
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant16
Cystic fibrosis liver disease in the post-modulator era15
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes15
Casting light on the many facets of sarcoidosis14
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing14
Tobacco treatment in the setting of lung cancer screening14
Sarcoidosis and frailty: recognizing factors that foster holistic resilience14
What causes cough in pulmonary fibrosis, and how should we treat it?14
Progress for all: addressing disparities in sarcoidosis14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens14
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice14
Home monitoring of coronavirus disease 2019 patients in different phases of disease13
Digital inhalers for asthma management13
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease13
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease13
Acute rejection post lung transplant12
Imaging in peripheral bronchoscopy12
Editorial: Are we ready for prime time?12
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators12
Effectiveness and safety of coronavirus disease 2019 vaccines12
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort11
Infection control in cystic fibrosis: evolving perspectives and challenges11
Patterns of progression in non-IPF fibrotic interstitial lung disease11
Novel insights in fibrotic pulmonary sarcoidosis11
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism11
Exhaled breath analysis in interstitial lung disease11
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown11
Multidisciplinary care in nonmalignant central airway obstruction11
The changing landscape of infections in the lung transplant recipient10
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities10
Telerehabilitation in pulmonary diseases10
The association of preexisting severe asthma with COVID-19 outcomes10
Editorial: ‘What is your occupation?’: historical snippets10
Altered pharmacology and toxicology during ageing: implications for lung disease10
Adenotonsillectomy: the good, the bad and the unknown10
Epigenetics and aging: relevance for sleep medicine10
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future10
Right ventricular assessment in pulmonary hypertension9
Pulmonary rehabilitation in idiopathic pulmonary fibrosis9
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?9
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians9
Approach to the hospitalized patient with pulmonary arterial hypertension9
Ergonomics in bronchoscopy9
Prader–Willi syndrome: an update9
0.076095104217529